OSR Health, Inc. - common stock (OSRH)

CUSIP: 68840D102

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+374,107
SEC-reported price per share
$0.32
Indexed holders
14
Value change
+$102,341
Number of buys
9
Number of sells
6
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,294,118

Security key

68840D102

Report period

Q2 2026

Indexed institutions

14

Top holders

10

Ownership snapshot

Top reported holders of OSRH - OSR Health, Inc. - common stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bellevue Global Life Scie...
Disclosed value leader
BCM Europe AG
Comparable rows
2/15
Latest evidence
24 Jun 2026
3/4/5 13D/G 13F Lead comparable stake: 88% 13 rows are not safely comparable across share classes. 13D/G row: Bellevue Global Life Science Investors LLC Showing 1-6 of 15 holder rows.

Quick read

Bellevue Global Life Science Investors LLC leads the comparable SEC ownership view at 88%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bellevue Global Life Science Investors LLC's linked filing trail.
Comparable ownership Top 2
Bellevue Global Life Science Inve... 88%
joint protein central inc. 3.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bellevue Global Life Science Investors LLC
3/4/5 13D/G
10%+ Owner · Bellevue Capital Management LLC
88%
Reported 13D/G · 31 Dec 2024
$20,005,000
2,043,500 shares
— 14 Feb 2025
joint protein central inc.
13D/G
3.4%
Reported 13D/G · 24 Jun 2026
$396,000
1,200,000 shares
$0 24 Jun 2026
BCM Europe AG
3/4/5
10%+ Owner
—
denominator unverified
$75,316,340
7,531,634 shares
— 14 Feb 2025
Bellevue Capital Management LLC
3/4/5
10%+ Owner
—
denominator unverified
—
3,123,970 shares
— 14 Feb 2025
David Jin Yoo
3/4/5
Chief Financial Officer
—
mixed-class rows
$200,000
40,000 shares
mixed-class rows
— 23 Mar 2023
In Chul Chung
3/4/5
Director
—
mixed-class rows
$200,000
40,000 shares
mixed-class rows
— 14 Feb 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
14
Shares
667,011
Indexed holders
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 indexed holders
11
Q2 2026 indexed holders
14
Indexed holder difference
3
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .